Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
Recruiting · NCT07553338 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-05-22 | NCT07553338 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Weill Medical College of Cornell University | 276 |
| William H. Donner Foundation | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Weill Cornell Medicine Brain Health Imaging Institute | New York | United States | 1 |